London FTSE fell 2.76 percent in one week

Published: 06:31, September 28, 2014

London’s FTSE fell 2.76% in just one week, its sharpest decline since June 2013, including the 9.68-point marginal gain to 6,649.39 at the end of Friday. London stocks took a beating when the Obama administration said it was taking measures to stop tax inversion.

Tax inversion is when a company merges with a foreign one and then moves its headquarters abroad where corporate tax is lower. Corporate tax is 21.5% in the UK, compared to 35% in the United States. UK pharmaceutical companies’ stocks had been rising all year on investor expectations that Pfizer and some other US drugmakers would acquire some of them.

News that the US government was closing the tax-inversion loophole sent pharma stocks tumbling in London.

The news that Tesco plc., the world’s second largest retailer after Wal-Mart, had inflated its profit guidance by ₤250 million, sparking the suspension of four executives and an investigation by Deloitte, did not help either. Struggling competitor J. Sainsbury fell 7.9% during the week after Santander warned that the supermarket may reduce its dividend.

FTSE

Despite a slight gain late on Friday, the FTSE had a bad week.

Sports Direct’s boss, Mike Ashley, spooked investors because he used the company’s balance sheet to bet on Tesco.

With US stocks – including Dow Jones, Nasdaq and the S&P’s 500 – having the worst Thursday in months, stocks across the world appear to have a mind of their own.

Nobody could understand why shares in the US took such a beating. Fortunately, on Friday things improved (in the US, not really in London).

There is a lot of disconcerting news out there that may have pushed investors into a more cautious mood. Sanctions against Russia have pushed German business confidence into the ground, the country reported a GDP shrinkage in the second quarter, and that was before sanctions were intensified.

The Eurozone is not growing and its inflation rate continues to fall. China’s GDP growth looks less solid and sustainable, Japanese consumer demand has dried up, Brazil is officially in recession, France’s and Italy’s prospects look dire, and the time for the Fed to raise interest rates looms closer.

The only economies that appear to be doing really well are the US’ and UK’s.

So, what will happen next week? Most bets are on the strong US GDP figures (4.6% growth in Q2) keeping people happy for a while.

Christian Nordqvist Avatar

Other News

Plumbing or college: weighing pay, training and AI exposure

Sep 13, 2026

Why more advanced VR equipment does not always feel more real

Sep 13, 2026

VR pilot training shows promise before a student’s first real flight

Sep 13, 2026

Family businesses face a gap between succession plans and readiness

Sep 13, 2026

EU keeps battery recycling targets as industry prepares for tougher recovery rules

Sep 13, 2026

UK firms report patchy recovery while hiring plans stay flat

Sep 13, 2026

Positron wins new backing for an AI chip built around cheaper memory

Sep 13, 2026

EU employment rises, but 24 million people still want more work

Sep 13, 2026

Why the Internet of Things still matters for businesses

Sep 12, 2026

Deep discounts can weaken later purchase interest, study finds

Sep 12, 2026

Household saving study finds large differences in how people value the future

Sep 12, 2026

Cybersecurity budget research puts expected losses ahead of spending targets

Sep 12, 2026

UK trade deficit narrows to £9 billion over three months

Sep 12, 2026

Munters expands Virginia factory to make data center chillers locally

Sep 12, 2026

Digital literacy report calls for skills training beyond network coverage

Sep 12, 2026

Berkeley’s healthy checkout rule linked to lower soda sales, study finds

Sep 12, 2026

France cuts growth forecast to 0.5% and announces fresh budget measures

Sep 12, 2026

Kroger cuts sales outlook as online growth helps support earnings

Sep 12, 2026

Gasoline pushes US monthly inflation higher ahead of Fed meeting

Sep 12, 2026

How AI is changing the pharmaceutical industry

Sep 11, 2026